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Renal Division:
Searching lor prevention,
solving complications
By Sharon Stephens Murphy

There are about 25,000
people in the United States on
dialysis. The cost for dialysis
is estimated at $350 million
and the cost of transplanta
tion is $20-25 thousand per
patient.

In 1969 a Wall Street Journal article
reported, "Only about 1,700 Americans
currently receive treatment while an
estimated 8,000 people will die this
year for lack of it."
The treatment referred to is hemo
dialysis for victims of kidney disease.
At that time nine out of ten victims
would die because the process was un
available to them.
The treatment and research of this
disease is relatively new, dating back
to the 1940s when hemodialysis was
used experimentally. In the 1960s it
became more widespread although sti II
not financially feasible for everyone.
Since then state and federal funds
have guaranteed treatment for those
afflicted .
Today, the statistics are staggering.
There are about 25,000 people in the
United States on dialysis. The cost for
dialysis is estimated at $350 million
and the cost of transplantation is $20
25 thousand per patient.
Saulo Klahr, M.D., director of the Di
vision of Renal Diseases, stresses that
the School of Medicine is involved in
research to find ways to treat and im
prove the quality of life in patients
who have the disease as well as to try
to find the causes and cures.
"If renal disease continues at the
rate we are seeing now," he says, "it
is calculated that 50 to 60 out of one
million people are going to require
dialysis each year. In the United States
alone, this would give us more than
10,000 new people every year on dialysis
programs."
If this trend is actual, Klahr says the
projected cost for the dialytic popula
tion for 1980 would be $1 bill ion.
"Because of the economic considera
tions, in add ition to the fact that the
renal patient on dialysis treatment
lacks quality of life, we must work to
prevent the further rise of kidney dis

ease," Klahr says. "It's an economic
as well as a human problem."
Klahr notes a similar situation in
the 1940s when the i ron lung was de
veloped. "If the scientists had con
centrated just in the development and
manufacture of iron lungs, we never
would have found a polio vaccine. As
a result, thousands of people would
now be living in iron lungs."
One of the primary known causes of
end-stage renal disease is glomerulo
nephritis. "About 60 to 70 per cent of
all the people who require dialysis are
patients who have had this disease,"
says Phillip Hoffsten, M.D., assistant
professor of medicine, who is studying
glomerulonephritis. "Many times we
know this disease exists long before
end-stage renal failure occurs.
"Most people are diagnosed while they
still have sufficient kidney function to
support a normal life," Hoffsten ex
plains. "A person may have glomerulo
nephritis without it causing any symp
toms. Some people live a normal life
for years with glomerulonephritis, while
others have a much shorter time before
renal insufficiency begins. With the ad
vance warning early diagnosis provides,
the patient can prepare for the expected
outcome of the disease. The object of
research in this field is to avert progres
sion of the disease.
"Although people have been studying
glomerulonephritis for about 25 years
we still know little about the disease,"
Hoffsten says. "We know it is a very
diverse disease, with more than one
cause and that at present, medicine
does not know how to favorably alter
the course of the disease."
Usually the etiologic agent causing
glomerulonephritis is not known. There
have been cases in Africa in which the
organism which produces malaria is
the responsible antigen causing ne
phritis. Also, some patients who have
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had syphilis have developed antibodies
which are known to lead to glomerulo
nephritis. "We don 't know in a majority
of cases what the antigen is but it is
a good bet that in many of the cases
it may be a virus," Klahr says.
"While we know very little about
vi ral induced glomerulonephritis," Klahr
says, "there is strong evidence that
this might be one of thE: mechanisms
for the production of nephritis. When
there is an antigen (in this case a
virus) which causes the production of
antibodies, complexes of antigens and
antibodies are deposited in the kidneys
and produce renal disease. Dr. Hoffsten
is trying to understand how this hap
pens and how we can manipulate the
resulting renal disease with drugs."
In his research, Hoffsten is infecting
mice with a type of virus which causes
glomerulonephritis to progress in a
predictable way. He and his colleagues
are treating and manipulating this
progression to try to change the course
of the disease. It was during this work
that he found that glomerulonephritis
is not a hyper-immune state as thought
in the past but an immuno-deficient
condition.
"We have found that when we inject
this virus into the offspring, the mother,
who has not received the vi rus, de
velops an innocuous infection and be
comes immune by exposure to her
young," Hoffsten explains.
"Then, we take the mother's spleen
and give her offspring those spleen
cells which are immune . The babies
eliminate the virus and the glomerulo
nephritis which would normally occur,
does not.
"Of course, this is not yet practical
for application to humans because it
involves the transplantation of cells
from one person to another. But at least
on a conceptual basis it tells us the
real problem with the disease is not
hyper-immunity but rather immuno
deficiency.
"We are looking at the cells which
are responsible for the immunity in
the mother's spleen, whether it is a
specific kind , a lack of several or a
lack of a cooperative effort," Hoffsten
says.

•

"If renal disease continues at
the rate we are seeing now,
it is calculated that 50 to 60
out of one million people
are going to require dialysis
each year in the United States
alone."
Saulo Klahr, M.D.
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"Glomerulonephritis is the
most common cause of renal
disease in persons younger
than age 50."

liThe consequences of
untreated obstruction are
destruction of #c.idney tissue
reflected by loss of renal
function."

Phillip Hoflsten, M.D.

Mabel Pur#c.erson, M.D.

"The problem with glomerulonephritis
is very much the same problem as with
cancer. How does a cancer in you or
me continue to progress when normally
our immune system should eliminate
it? For some reason when we grow a
cancer or in this case a virus, our im
mune system is blinded and does not
recognize the foreign growth. When we
find an answer to cancer we'll have
one for glomerulonephritis too."
Glomerulonephritis is the most com
mon cause of renal disease in persons
younger than age 50. Later in the 60s,
70s and 80s arteriosclerosis and hyper
tension are prevalent causes for renal
disease.
Obstructive uropathy also can cause
renal disease. Mabel Purkerson, M.D.,
associate professor of medicine, is con
cerned with this problem.
"Obstruction to urine flow at some

point in the urinary tract occurs fre
quently," Purkerson says. "Lesions
which obstruct the urinary tract have
been found in about 3.8 per cent of
post-mortem examinations. Figures ob
tained from autopsies of uremic pa
tients show an incidence of about 25
per cent, including both patients in
whom obstructive uropathy was either
a contributory or a major factor of
renal insufficiency."
Purkerson says the incidence of ob
structive uropathy in relation to other
caUSes of renal disease increases in
certain age groups, such as infants and
children with congenital abnormalities
(aberrant vessels, constricting bands)
of the urinary tract and elderly males
in whom prostatic hypertrophy occurs
frequently. Stone formation in the uri
nary tract may be a cause of obstruc
tion in any age group.

rill

"The consequences of untreated ob
struction are destruction of kidney tis
sue reflected by loss of rena I function,"
Purkerson says. "However, obstruction
is generally a remediable cause of kid
ney failure which requires prompt and
accurate diagnosis and appropriate
therapeutic maneuvers to preserve and
restore renal function."
One specific area Purkerson is study
ing is the changes in salt and water
meta bol ism observed frequently in pa
tients with obstruction. She and John
Buerkert, M.D., assistant professor of
medicine at Veterans Hospital , have
developed and utilized animal models
of obstructive uropathy whereby these
changes in salt and water metabolism
are reproduced.
"These animal models permit the
study of mechanisms which might ac
count for some of the observed phe
3
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"There are many areas of
research because there are a
lot of patients who already
have advanced renal disease.
There is nothing we can do to
solve their initial condition.
What we want to do is solve
some of the complications."
Eduardo Slatopo/sky, M.D.

nomena in patients suffering loss of
renal function secondary to obstruc
tion," she says. "Better insight con
cerning the physiological changes oc
curring with obstruction has opened
new and important avenues in our un
derstanding and treatment of patients
with urinary tract obstruction."
While some causes of renal failure
can be corrected, for those who al
ready have end-stage renal disease, the
choices are few: dialysis, transplanta
tion or death. A major area of research
at the School of Medicine is to see
what can be done to improve the quality
of life for the renal patient.
"There are many areas of research
because there are a lot of patients who
4

already have advanced renal disease,"
explains Eduardo Slatopolsky, M.D.,
professor of medicine. "There is noth
ing we can do about solving their ini
tial condition. What we want to do is
solve some of the complications. Even
though the patient can be kept alive
with an artificial kidney the rena I dis
ease cannot be reversed and it is neces
sary to try and prevent some of the re
sulting problems."
W. Ernest Rutherford, M.D., assistant
professor of medicine and director of
the renal division at City Hospital, Kevin
Martin, M.D., research fellow, Slatopol
sky and Keith Hruska, M.D., assistant
professor of medicine, a're involved in
three interrelated areas.

One of their areas of research has
led to information and answers to the
problem of bone disease in patients
with renal disease who are maintained
on hemodialysis.
Bone disease is a concern in di
alysed patients because calcium ab
sorption is a very serious problem for
those with rena I disease. "Patients with
kidney disease do not absorb calcium
in the gastrointestinal tract as a well
person does," explains Slatopolsky.
"We know that one of the reasons ca 1
cium is lost in the stools is because of
low concentrations of vitamin 0 in
blood." Because vitamin 0 is first me
ta bol ized by the I iver and then by the
kidney, a person with renal disease is
unable to make a metabolite of the
vitamin. The result is inability to ab
sorb calcium. "We are changing dif
ferent factors in the diet, such as cal
cium, phosphorous, magnesium and are
adding new vitamin 0 metabolites
which are still experimental," Slatopol
sky says, "to try to correct the prob
lem."
A related complication is the re
tention of phosphorous. This also
causes a decrease of calcium in the
blood in direct proportion with the re
lease of parathyroid hormone (PTH).
Norma lIy, 70 per cent of phosphorous
from the diet should be excreted in
the urine. Slatopolsky and his col
leagues have been looking for ways to
control phosphorous retention wh ich
occurs in patients with renal disease.
They also have been experimenting
with phosphorous bi nders.
"Phosphorous binders don't taste
very good," Dr. Slatopolsky explains.
"They leave an after-taste and patients
feel nauseated and sometimes vom it.
Patients don't like it and it's very dif
ficult to convince them to take it in the
dry form. We have been able to make
a capsule, but found this greatly re
duced its binding potential."
Because the main source of the
body's intake of phosphorous is pro
tein, it is impractical to try to restrict
phosphorous from a patient's diet. A
solution was found by Robert Sparks,
professor of chemical engineering and
Norbert Mason, senior research a_sso

.
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"The average kidney
transplant requires two or
three days for clearing the
PTH build-up."
Keith Hruska, M.D.

•

ciate in chemical engineering. They de
veloped a new binder which can bind
phosphates a Imost exclusively in the
gastrointestinal tract and is active even
as a dehydrated gel.
Rutherford and Slatopolsky have
tested the gel and have had bread
sticks made with it. The bread sticks
taste normal and have few side effects.
Results have been excellent in patients
who eat the bread sticks, with phos
phorous under control in a week to ten
days.

With phosphorous and vitamin D
levels controlled, the deficiency of cal
cium can be corrected. This is a big
step because while the calcium de
ficiency is very small and difficult to
measure, its total effect multiplies over
the yea rs a person may have kidney
disease. "If you realize a renal patient
may have the disease for 20 years and
you multiply that small amount even
for a period of three years, you are
ta Iki ng a bout a very la rge amount of
lost calcium," explains Slatopolsky.

As the calcium in the blood de
creases, the concentration of calcium
drops and th is stimulates the para
thyroid glands and another complica
tion develops. Parathyroid hormone
(PTH) is released to maintain calcium
homeostasis. It stimulates the osteo
clasts which mobilize calcium from the
bone and put it back into the blood.
"This is very good for the blood, but
is detri menta I for the bones. And over
a period of time your bones deca Icify
and become very fragile and break
5
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"One of the major problems
with people on dialysis is that
they have accelerated
vascular disease."
Herschel Harter, M.D.
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easily," Slatopolsky explains.
Keith Hruska is working on a related
problem involving how the body handles
PTH . Hruska found that the patient
with renal disease has a high level of
PTH in the blood not only because of
increased production but because of
decreased destruction.
He found that while the kidney and
liver are both responsible for creating
fragments of the 1-84 amino acid chain
of PTH, the liver only has an uptake
mechanism for the intact hormone.
Since the kidney handles both the in
tact hormone and the N-terminal and
C-terminal fragments, it is the im
portant organ in the destruction of
PTH. As a result the dialyzed patient
maintains a high level of PTH.
Hruska is also evaluating the handling
of PTH following a transplant. "Renal
patients have high levels of PTH but in
most cases after a transplant the new
kidney is able to clear the buildup of
PTH. Levels then remain normal," he
says.
Hruska and his associates, Kevin
Martin and Jeffrey Freitag, M.D., re
sea rch fellow, recently have found that
the average kidney transplant requires
two to three days for clearing the PTH
buildup. "We're also studying why some
patients continue to have high PTH
levels after transplant surgery.
"In another study we're looking at
the effect of calcium and magnesium
on PTH action. We know levels of cal
cium will determine PTH release,"
Hruska explains, "but we think calcium
may also playa role in the actions and
degradation of PTH."
A method to measure PTH in the
blood developed by Slatopolsky brought
world fame to both the Division and
Slatopolsky. He immunized a rooster
with PTH about eight years ago and it
developed a very sensitive antibody
which enabled the measuring of PTH in
picograms. Although the rooster is dead
now, it left behind enough antibody to
supply the Division for a long time.
While the rooster was alive, the renal
division supplied laboratories allover
the world with the valuable antibody.
Also working on complications of
renal disease is Herschel Harter, M.D.,
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assistant professor of medicine and
medical director of the Chromalloy
American Kidney Center.
"One of the major problems with peo
ple on dialysis is that they have accel
erated vascular disease," Harter says.
"Thei r atherosclerotic vascu lar disease
accelerates at a rate faster than a d ia
betic. If patients are to survive for pro
longed periods of time, we must find
the cause for this metabolic condition."
More than 80 per cent of the patients
maintained on hemodialysis have dia
betic tendencies, Harter says. To evalu
ate the etiologies of this diabetic state,
Harter in conjunction with Irene Karl,
Ph.D., of the Division of Metabolism,
has been using the epitrochlaris muscle
of rats. Karl and David Kipnis, M.D., head
of the Department of Medicine, have
studied this muscle in normal and dia
betic mice. They found that in diabetic
rats there is an accelerated rate of
amino acid release. This protein break
down is not necessarily related to the
glucose that is being taken up by the
muscle.
Harter and Karl used uremic rat mod
els, and fed them low, medium and high
protein diets. After ten days on the re
spective diets the muscles were re
moved and incubated for one or three
hours to determine their metabolic
function. "We found that the uremic
muscle also had an increased release
of amino acids similar to the diabetic
muscle, although less severe," Harter
says. "However, while muscles from
diabetic animals have a decreased glu
cose uptake, the muscles from uremic
animals have an increased uptake.
There are several possibilities for this
finding, which we are currently evalu
ating.
"Our object was to improve the met
abolic function of the muscle. We
found that when we fed the rats a low
protein diet the muscle was more nor
mal. On the other hand, the muscles
from animals fed a high protein diet
were very abnormal. Thus it appears
that diet alone may affect these param
eters. It also appears that increased
glucose uptake and accelerated amino
acid release may not be related to the
same metabolic defect. There may be

different metabolic aberrations affect
ing each of the observed abnormali
ties."
Harter and his colleagues are study
ing several different aspects of the ap
parent diabetic tendencies of dialyzed
patients by utilizing the rat model, al
tering both diet and hormonal imbal
ances and thus hoping to correct the
defects. "Once we correct the diabetic
state we can expect to protect the pa
tient from vascular disease for a longer
period of time," Harter says.
Another complication affecting renal
patients is an increased incidence of
gastrointestinal disease. "It used to be
'thought that a high percentage of
dialyzed patients had ulcers," Harter
says. "To examine this possibility we
evaluated 100 patients using gastroin
testinal X-rays, endoscopy and biopsy
of the stomach and duodenum in con
junction with David Margolis of the
Department of Gastroenterology. We
found a very high incidence of gastritis.
Approximately 40 per cent of our pa
tients, most of whom were asympto
matic, had some degree of gastritis and
that was confirmed by biopsies," he
says. "No ulcers were documented. We
took the most severe cases and treated
them with a calcium carbonate prepara
tion.
Fifty per cent of the patients im
proved. Thus it appears that gastritis
and duodenitis is an extremely frequent
complication of uremia which may be
benefited by conventional medical man
agement. We plan to study transplanted
patients next."
Another current study is underway in
which the researchers are studying
hormones in chronically dialyzed pa
tients. "No studies have been well per
formed on the responses of epinephrine
and norepinephrine in chronically dia
lyzed patients," Harter says. "These
two hormones assist in the control of
your blood pressure. We will study the
clearance of norepinephrine by the ar
tificial kidney in non hypertensive and
hypertensive dialysis patients. We will
aIso document thei r respective re
sponses to position, med ications and
known stimuli of norepinephrine re
lease. We also plan to evaluate the re

sponses to medications and stimuli in
patients with severe renal disease who
are not yet on dialysis."
This, as well as other research in the
Renal Division, is designed to improve
the qua I ity of I ife for the patient with
severe renal disease. Harter and his
associates recently had the opportunity
to evaluate a new device which, in the
near future, may greatly improve the
quality of dialysis and mobility of the
rena I pati ents.
Called the Wearable Artificial Kidney
(WAK), the device was developed by Dr.
Willem Kolph, of the University of
Utah, who was also the first person to
develop dialysis. With the assistance of
Carol Weerts, coordinator of the dialy
sis unit. Harter evaluated the WAK and
made recommendations for improve
ments.
"The WAK is compact, lightweight
and wearable. However, the machine is
30 per cent less efficient than a regular
dialysis machine and still must use a
dialysate bath, making it cumbersome.
Newer sorbents will improve its effi
cacy."
One of the advantages of the ma
chine is that a person with an office
job could dialyze at work with the port
able unit, leaving more free time for
the patient and his family. The other
advantage is that a renal patient could
travel with much less difficulty using
the portable unit.
"We are going to recommend some
improvements," Harter says, "and if
these things can be done, I think it will
be a very good product."
While research, both clinical and
basic, is a major responsibility of the
Division, it isn't the only one. It also is
involved in teaching and patient care.
Postdoctoral fellows are trained by
the Division and 24 senior medical stu
dents each year rotate through the Di
vision.
The Division also operates and staffs
the W.U. Chromalloy Kidney Center
which includes the six-bed Kuhn-Pelton
unit. Patients with end-stage disease
come here for treatment and dialysis,
or for transplantation. Renal housestaff
are responsible for hospital patients with
kidney problems and renal division
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"The goals of renal disease
research are to prevent future
generations from the threat
of renal disease and to
improve the quality of life for
those who have no other
choice than dialysis."
Saulo Klahr, M.D.

specialists serve as consultants to
other physicians.
Renal disease has many facets and
most researchers agree that the com
plete cure for it is many years away.
As in most research, one of the major
factors is adequate funding. Although
the cost for dialytic population will
cost $1 billion in a few years, renal re
search still isn't a priority.
"In the past fifteen years it has come
a long way," Klahr says. "We used to
be concerned on Iy with treati ng end
stage renal disease. Efforts began in
1960 to develop better and more effec
tive ways of dialysis and transplanta
tion. In the '60s, great strides were
made in transplantation, but there has
been little change in this decade.
"The emphasis now," Klahr says, "is
on the prevention of the disease, as
well as solutions to some of the com
plications which weren't evident before.
The goals of renal disease research are
to prevent future generations from the
threat of renal disease and to improve
the qua I ity of Iife for those who have
no other choice than dialysis."

The regular dialysis machine (above)
compared to the recently developed
Wearable Artificial Kidney WAK (below).
While the WAK is 30 per cent less effi
cient it does provide greater mobility.
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· Those Dlise..abl~ alle..gies:
nelV inle..esl in a common illness
By Glenda King Rosenthal
~

.

~
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Approximately 10 per cent of the
American population, including chil
dren and adults, is affected by it. Of all
the chronic illnesses, it is the number
one cause of absenteeism in schools.
Many millions of dollars in loss of
manpower are caused by it every year.
At Washington University's own Med
ical Care Group, more than four per
cent of the patients are treated for it.
The problem may not be fatal , but al
lergic disease can be a debilitating,
confining illness, and also can be fi
nancially important, when viewed over
a lifetime .
Timothy J. Sullivan, M.D., assistant
professor of medicine and director of
the Adult Allergy Clinic at the School
of Medicine, says, "A little mathemat
ics makes the problem obvious. There
are some 220 million people in the
United States and at least 10 per cent
of them have an active allergic dis
ease. The problem is there are fewer
than 2,000 allergists in this country to
treat illnesses which affect more than
two million people. That's a rather
alarming ratio."
Fewer than half the medical schools
in this country have someone on the
faculty who spend their full-time inves
tigating and caring for patients with al
lergic diseases. "Consequently," Sulli
van says, "a large number of physi
cians graduate from medical school
with no more than a cursory knowledge
of the immune system and diseases re
sulting from immune inflammation.
" I must admit I was brought up on
rather traditiona I grounds med ica Ily. I
was educated in a medical school
which didn't have anyone on the facul
ty who treated allergic or immune dis
eases. We used hospital ized patients
almost exclusively as our examples of
important illnesses," Sullivan says.
"The allergic diseases, with the excep-

tions of very severe asthma, shock re
actions or anaphylaxis, simply aren 't
seen in the hospital. It's rare that the
allergy patient being treated for his ill
ness ever needs hospitalization."
Sullivan says most medical stu
dents are educated to bel ieve that if
an illness isn't potentially fatal, it's a
trivial one. If it's chronic and mild, as
most allergic diseases are, it is con
sidered to be vastly less important
than an acute, disruptive illness of
short duration.

"I think because of these rather
practica I factors, medica I students,
myself included, simply have not been
made aware of how prevalent these ill
nesses are and how economically im
portant they are if nothing else."
Rheumatologists have to take care
of some immune illnesses, Sullivan
says, because a high proportion of
rheumatic diseases are caused by im
mune mechanisms. "There is an over
lap. But, nevertheless, rheumatologists
really have little interest in the large
subset of immune illnesses which
manifest themselves as allergies, such
as asthma, hayfever, hives or anaphy
laxis.

" Unfortunately, this aspect of medi
cine really doesn't generate much in
terest in medical schools," he says, "It
usually isn't until a physician gets out
into practice that he is confronted with
the need to evaluate and treat allergic
illnesses. Naturally, it's hard to get ex
cited about an illness you have never
seen.
"As a student, asthma was some
thing you thought you could quickly
come to grips with by opening a book
and reading about the proper treat
ment," Sullivan says. "I didn't regard
hayfever or urticaria as significant ill
nesses while I was in medical school.
It's not like bleeding from an ulcer. But
when we look at it on a larger scale,
spread out over a lifetime, it's deserv
i ng of some attention. But it is that
kind of thinking, which I certainly
typified, that's given us the situation
which exists today. We have too few
specialists for too many patients, with
too little understanding of the pro
cesses involved."
The development of approaches to
the treatment of allergies has almost
exclusively been dependent upon previ
ous trial and error, because there was
virtually no understanding of why a
treatment was working. A prime exam
ple is the use of allergen injections to
desensitize allergy patients. As early
as 1910 physicians had empirically dis
covered a way of giving injections of
allergens to reduce the severity of al
lergies.
"In the late 1800's, German physi
cians began to make anti-sera against
everything they could isolate," Sulli
van says. "The first large success was
in the treatment of diphtheria. Horse
anti-serum was developed against the
diphtheria toxin. It could prevent the
appearance of lethal aspects of the dis
ease, or it could stop them once under

;:.
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way. Consequently, a lot of enthusiasm
was generated for developing anti-sera
against practically everything."
However, it soon became clear that
injecting horse serum into a person
might cure the illness, but a wide va
riety of new problems would develop.
"Soon people became allergic to horse
serum," Sullivan says. "An attempt was
then made to immunize people them
selves, a much more efficient ap
proach. It was that kind of thinking
either giving an immune serum or
causing patients to make their own
which prompted physicians in the late
1800's to believe they could prevent
virtually any illness through immuniza
tion."
In this milieu physicians began in
jecting extracts of pollens, mold
spores, dust and other materials into
allergic people in an attempt to im
munize and thereby protect them. "We
now know the improvement which oc
curred had little to do with immunizing
a patient against pollen," Sullivan
says. "The mechanism by which it act
ed was quite different from the anti
body production physicians intended
to activate. Yet, the upshot was that it
worked. Because it didn't work for all
people, however, there was an incen
tive to keep looki ng."
A variety of medications for the
treatment of a Ilergies were subse
quently discovered, again by trial and
error. German physicians extracted
adrenal glands and found that in them
was a substance which had several
striking
pharmacologic
properties.
"They called it adrenalin," Sullivan
says. "It was quickly found that adren
alin could reverse many types of al
lergic reactions. By the turn of the cen
tury , physicians were administering
adrenalin to people with asthma and
a variety of other allergic reactions.
Again, the mechanism was not under
stood, but it didn't make a lot of dif
ference at a time when no other drugs
were available. It worked nicely."
Theophylline is another example of
a chance finding for the treatment of
asthma. "To this day I am unable to
determine why physicians first tried

Mast cells: where histamine is pro
duced and stored.

theophyll ine for asthma treatment,"
Sullivan says. "It was one of a family
of d rugs isolated from tea and coffee
and then synthesized by the chemists;
it was simply tried and it worked.
"The upshot of this is the major
drugs we use to treat allergic diseases
were developed empirically. Injection,
adrenalin and theophylline therapy
were well underway by the mid-1930's.
All of this was accompl ished without
the sl ightest idea-although plenty of
theories existed-{)f how it worked."
According to Sullivan, the next major
add ition to the treatment of allergic
diseases came with the development
of antihistamines around the time of
World War II. Histamine was recog
nized as an important mediator of al
lergy as early as 1910, and in 1937
French chemists succeeded in design
ing drugs to block histamine actions.
"An understanding of one aspect of
the problem led to a specific, effective
treatment," Sullivan says. "Our incom
plete understanding of other funda
mental processes in allergy has severe
ly limited the development of more
specific cures. Steroid hormones intro
duced in the 1950's and now cromolyn
sodium are again being applied to al
lergic diseases with some success."
Sullivan feels this empirically ar
rived at treatment works fairly well in
the management of most allergic dis
eases. "However," he says, "there are
some treatment failures, many times
despite expensive, long, drawn-out

treatment. So, from the poi nt of view
of just treatment alone, we're in a
quandary. We have some effective med
ications, but we only pa rtia Ily under
stand how they work. I view this as a
rather large, significant problem in ap
proaching the remaining therapeutic
impasses.
"We can handle most of our allergy
patients but there are a good number
of patients who are still refractory and
are only partially helped by injection
therapy or desensitization. Ou r em pi r
ically arrived at tools have carried us
a long way, but we clearly need delib
erately developed medications and in
terventions."
According to Sullivan, the National
Institutes of Health are trying to en
courage and support the development
of academic people who study, inves
tigate, and teach the care of immune
diseases. In conjunction with this idea,
Sullivan is the recent recipient of an
Allergic Diseases Academic Award .
"The NIH and the Department of
HEW have begun to put a greater em
phasis on this very neglected area in
clinical medicine," Sullivan says. "One
of the devices they're using to encour
age the clinical investigation and clin
ical teaching of immune diseases is to
specifica Ily allocate financia I support
for the development of academic aller
gy people."
Sullivan feels there is definitely an
educational gap in the study of allergic
diseases. "The award should bridge
several gaps, primarily that of develop
ing investigators and educators," he
says. "That's really the stated purpose,
but there is an even more important
one. That is to provide each institution
with an academician and educator in
allergic diseases. What's happening on
an overall scale is we're attempting to
get medical educators and investi
gators in places where they can ac
quaint medical students with the prop
er evaluation and care of patients with
allergic diseases. We also want them
to know enough to be able to recogn ize
when the patient needs help from a
specialist, even though the majority of
these patients can be cared for by any
11
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physician with a basic understanding
of the principles involved."
There has been an overwhelming in
crease in the understanding of the im
mune system over the past fifteen
years. According to Sullivan, there is
a great deal now known about the fun
damental mechanisms by which im
mune diseases occur, and specifically
a great deal is being learned about the
allergic diseases. This opportunity to
apply rapidly accumulating basic infor
mation to clinical problems is another
important reason why the NIH is now
encouragi ng investigators to devote
their clinical and research attention to
the immune system.
Another reason is the new, effective,
but potentially dangerous medications
used for some patients. "Use of many
of these drugs requires a great deal of
familiarity which most physicians don't
as yet have," Sullivan says.
A unique knowledge of immune ill
ness is also necessary in effective in
jection therapy. Sullivan feels this
has to be regarded as potentially lethal
intervention. "We're giving the patients
substances to which they are extremely
sensitive, and if it isn't done properly,
it could prove fatal. The improper use
of these materials killed a child this
year in East St. Louis. It is not a casual
undertaking," he says.
The NIH is also encouraging a
skilled knowledge of injection therapy.
This type of therapy can be expensive
in time, as well as money. "Some al
lergy patients require weekly or bi
weekly injections for a year and then
monthly injections for another couple
of years," Sullivan says. "That's the
only way of intervening in an allergic
illness when the pharmacologic agents
we currently use fail."
The cost of this therapy precludes a
lot of people from eagerly seeking care
for allergy problems. Even though it's
spread out over a long period of time,
Sullivan says that in this community
an evaluation can cost anywhere from
$125-$300 depending on the nature of
the illness and how many X-rays are
necessary. "This cost isn't too different
from an internist's work-up on some
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one with liver or kidney disease. The
difference is it is not likely to be a fa
tal illness. It is an avoidable expense."
People are more likely to seek help
for their children than they are for
themselves. "Asthma in children is
much easier to treat when the disease
is of recent onset. But the point is, a
lot of people feel obstructed from
seeking care for an allergic disease be
cause they can live with it and have
other pressing demands on their re
sources."
Sullivan hopes the recognized need
for specialized allergy care will influ
ence insurance companies to pay for
outpatient treatment. "More and more
insurance companies are willing to pay
for outpatient ca reo There wi II be more
funding available for the general phy
sician to take care of allergy problems,
if they know how. There also will be
more people seeking care on a private
basis from allergy specialists."

Sullivan hopes that through his NIH
sponsored research a better under
standing of the immune system will de
velop, along with a more rapid, effec
tive and efficient way of clinically
treating allergy patients.
"We now know, for example, that a
unique IgE antibody is responsible for
a lIergic reactions," he says. "This anti
body appeared late in the development
of animals, and it's found only in mam
mals. The important point is this just
isn't a residual part of the immune sys
tem. It's something that deliberately
evolved, and in the past two years it's
become clear why."

According to Sullivan, the IgE anti
body appears to be a protective device
against parasites. As a general rule,
people in tropical countries don't have
hayfever or asthma, but they do have
pa rasites.
"One British study showed that chil
dren coming from tropical countries
to Britain had virtually no asthma or
hayfever," Sullivan says. "But within
five years of their arrival, they had
the same percentage of hayfever and
asthma as the British children."
There are many reasons why that
could be, but the prevailing attitude,
according to Sullivan, is that their im
mune system, which was previously in
volved in the protection against para
sitic infection, became idle. "Their im
mune system began to focus on en
vironmental factors it had no business
focusing on.
"It's believed that the more indus
trialized we become, the more likely
our immune system will attack environ
mental invaders such as dust, pollens,
mold spores and animal danders. So,
the allergic illnesses appear to be a
spectrum of illnesses that are in part
a direct result of improving our lives,"
Sullivan says.
Sullivan became interested in exact
ly what happens during an a Ilergic re
action, because he felt a thorough un
derstanding would permit researchers
to modulate the reaction at will. "The
specificity of the allergic reaction
comes from the production of these
IgE antibodies, which are ordinarily
produced when we're invaded by para
sites. This antibody doesn't circulate
in the blood and attack antigens the
way other antibodies do. It does circu
late, but in very small quantities. On
the other hand, it becomes bound to
tissue cells which are called mast
cells."
The mast cells are virtually the only
place in the body where histamine is
produced and stored. "Let's take the
example of people allergic to ragweed
pollen. When they breathe it in, pollen
hits their eyes, nose, airways and skin
and pollen proteins begin to diffUse
through the tissues.
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Timothy J. SuI/ivan, MD., hopes to gain new insights into the workings of the
immune system through laboratory research.

"The person who is allergic to these
substances has already made specific
IgE antibodies after previous exposures
and has coated the surface of the mast
cells. When the ragweed proteins en
counter IgE on the mast cells, a reac
tion occurs which activates the mast
cell interior," Sullivan says. "This
causes the cell to release many kinds
of molecules, histamine being the one
that is best understood."
According to Sullivan, there are
enormous quantities of histamine in
these cells. "There isn't a tissue in the
body, except perhaps the brain, that
normally isn't partially regulated by the
mast cells in the tissues. Th is biolog
ical concept developed in very primi
tive animals. The biologic idea of mak
ing the secretion severe and specific
enough to stop invading parasites came
later.
"The crux of our stUdies on mast
cells," Sullivan says, "is that by study
ing the isolated cell we hope to be able
to ferret out which of the pharmacolog
ic actions that we know to occur in
complex tissues can be attributed to
effects on the cell and which are due
to alterations in environment. Our ob
jective is simple: the more perfect reg
ulation of mast cell function in the al
lergic situation."
Sullivan hopes that in the future this
dimension of the immune response will
be effectively controlled. Until recently,
drugs to treat the allergic diseases
have been accidentally discovered.
"We're just beginning to systematically
work out the mechanisms of actions of
the drugs which are currently used. We
have to understand the mast cell func
tion to pharmacologically regulate that
function when the diseases are appar
ent. It's been impossible so far to pre
vent the formation of IgE antibodies."
Attempts have been made to under
stand what portion of the IGE molecule
binds to the surface of the mast cell.
"As soon as we understand that, we'll
attempt to manufacture molecules
which resemble portions of the IgE
molecule. This should in turn prevent
binding to the mast cell," Sullivan
says. "If we can do that, we can block
13
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all of the IgE mediated events because
it has to be attached to the surface of
the cell to deliver its signals."
Current injection therapy apparently
doesn't significantly affect the forma 
tion of IgE molecules, even though the
patient might be markedly better. Ac
cording to Sullivan, it appears that the
mechanism by which these injections
work is a combination of many things.
"The major factor seems to be in pre
venting the mast cells from producing
these abrupt secretions which cause
symptoms. The body can cope with
small amounts of these mediator mole
cules. It's the abrupt, explosive release
of histamine that causes a clinically
apparent allergic reaction, such as an
allergic reaction to penicillin .
" For example, if you were to hold in
your hand the amount of ragweed pol 
len that hits you each year, you could
barely see it," Sullivan says. "Yet that
tiny amount of pollen provokes intense
symptoms."
However, over a period of six to nine
months, a patient's tolerance can be
built up to the point of desensitization .
"We can markedly change the patient 's
degree of sensitivity," Sullivan says.
"The question is, have we reduced
their sensitivity to a level at which
they don't clinically react. We can
build up the degree of tolerance in
everybody; we can reduce the clinical
symptoms in 8 out of 10 people."
The ideal would be to develop a level
of tolerance in the allergy patient so
their clinical symptoms would be non 
existent. Or, if the symptoms were
there, they could be easily suppressed .
"Currently it takes a long time for de
sensitization therapy," Sullivan ex
plains, "and there are those 15 out of
100 patients who don 't respond . This
type of therapy isn't a cure; it is a neg
ative modulation which then makes the
drugs more satisfactory. We're now in
vestigating why the cell turns off when
it is gradually presented with increas
ing quantities of an allergenic sub
stance ."
Sullivan hopes that by biochemically
understanding how a cell is activated,
it will permit researchers to ask how
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the cell becomes deactivated. "These
processes cannot be separated or
solved independent of each other. We
are now able to investigate how the
gradual presentation of antigen turns
the cell off. Hopefully by understand
ing that process we can come to grips
with a more rapid , effective and effi
cient way of dealing with people."
At the present time, none of the cl in
ically important allergic diseases can
routinely be cured . Most can be easily
suppressed with avoidance measures
or medications which don't make peo
ple ill. However, Sullivan points out
there is still that 1 in 100 patients who
doesn't obtain adequate relief from any
of the current methods.
Sullivan emphasizes that one gener
ally measures research in terms of
years, not weeks or even months. "We
are trying to follow a systematic line
of investigation. The price one pays for
that," he says, "is research progress
appears relatively slow, even though it
is definite and thorough."
In the next five years, Sullivan hopes
to have a fairly good understanding of
the major control mechanisms which
regulate mast cell function. "Through
our research we may generate the de
liberate development of a whole new
family of medications, as opposed to
the chance findings we've had in the
past. What's certain is that we'll know
quite a bit more about how the mast
cells are regulated, and in turn how to
purposely regulate them."
Su II ivan became interested in study
ing the immune system while on a tour
of duty with the Special Forces in
Vietnam. "I realized that many tropical
and parasitic illnesses are a result of
immune attacks on infectious orga
nisms and / or the failure of protective
immunity. I became interested in the
immune system by living among people
with a spectrum of illnesses I had nev
er seen before. One cou Id see the de
structive and the protective aspects of
the immune system. We usually don't
see the immune system in such obvi
ous activity. In a tropical country
where sanitation is poor, one constant·
Iy sees people battling against environ·

menta I problems and infectious pro
cesses. One quickly realizes how im 
portant immunization is when you see
these probiems in action. The immune
system became very real to me, and
this only emphasized how little we un
derstand it."
Sullivan found that a disease such
as malaria is a satisfying one to treat
because the patient feels so much bet
ter in a short time. "Because I was in
the same location for thirteen months,
I often treated the same patients for
ma la ria fou r or five ti meso It's extreme
ly satisfyi ng to take care of people, but
one has to balance long-range gratifica
tion against immediate gratification .
That's the difference between treating
a disease and solving it."
Sullivan feels he has to balance
what he thinks his effectiveness can be
as an educator and investigator against
a possible role as a full-time clinician .
"I hope I can teach enough about my
chosen area to developing physicians
so they can go out, amplify that knowl
edge, and apply it. Secondly, I hope to
be lucky enough and smart enough to
improve the way immune diseases are
treated . I find it extremely rewarding
to be tackling problems, solving some
of them, and participating in the evolu
tion of medical knowledge.
"Very seldom will someone have a
dramatic breakthrough in the labora
tory that's going to help millions of
people. One can't be so grandiose as
to expect that will happen," he says.
"But laboratory research on the im
mune system can add a great deal clin
ically. We now know so little about the
human immune system; there are many
gains to be made in the field. I hope to
be able to translate some of these lab
clinical
oratory
phenomena
into
changes. It's my hope that I'm going to
be effective enough as an investigator
and educator that my time here will
have considerably more impact than
what I might have accompl ished treat
ing patients with our current insights."

Harvest time is particularly difficult for
the allergy sufferer.
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War on food additives
continues
By Linda Nielsen Weller

Each year food processors add more
than 200,000 tons of monosodium glu
tamate (MSG) to foods in largely un
regulated amounts. Yet, MSG is known
to have toxic effects on experi menta I
animals, especially immature animals.
In light of this, a scientific advisory
committee recommended in November
that MSG, a long with hyd rolyzed vege
table protein (HVP), be banned by the
FDA in infant and junior foods.
Strongly supporting this measure is
John W. Olney, M.D., associate profes
sor of psychiatry and neuropathology,
who has supported a ban since 1969.
His resea rch has shown that MSG
causes brain damage when adminis
tered by mouth to young animals.
The Advisory Committee's recom
mendation that MSG and HVP be
banned received little notice. For one
reason, the additive HVP is not well
known and second Iy, most people be
lieve MSG was taken out of baby foods
years ago.
Olney says the latter is a miscon
ception. "MSG really was not taken out
of infant and junior foods and an of
ficial ban is the only appropriate way
to deal with the problem."
Olney reported new findings in No
vember at the annual meeting of the
Society for Neurosciences in Toronto .
Theodore J. Cicero, Ph .D., associate
professor of psychiatry and neurobiol
ogy, also attended. They said even
when MSG is administered to animals
in doses lower than those required to
cause bra in damage, it resu Ited in ele
vated blood levels of two hormones.
Testosterone, the male sex hormone is
one of the hormones affected. The
other, luteinizing hormone (LH), is a
pituitary hormone which is transported
in blood to the testicle where it stimu
lates output of testosterone.
Olney and Cicero say the basis for
these hormonal changes is that MSG
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is able to stimulate certain brain cells.
It is by stimulating these cells, the re
searchers believe, that MSG causes
sudden changes in hormonal levels.
"We cannot say yet whether the ef
fects of MSG on hormonal systems will
give further basis for questioning the
widespread use of the additive in
foods," Olney says. "Many more studies
will have to be undertaken. In these
studies it will be important to ascer
tain further the effects of daily MSG
intake on the immature organism. We
suspect that even at relatively low
doses, it might cause subtle but re
petitive disturbances in certain hor
monal systems which are important
for normal growth and development."
The November recommendation came
from a scientific committee of the
Federation of American Societies for
Experimental Biology (FASEB). The
committee was asked in 1973 to study
MSG and HVP by the Commissioner of

•

FDA who was under pressure at the
time from the Senate Nutrition Com
mittee.
What do the FASEB recommenda
tions mean to the consumer? "It is too
early to tell," Olney says, "but the MSG
and food industries probably will wage
new offensives to delay or obstruct reg
u latory action. The FDA has indicated
they will hold formal hearings to give
interested parties ample time to file
complaints against the FASEB recom
mendation .
"It will be interesting," Olney says,
"to see what action, if any, the FDA
finally takes. This is a tough regulatory
problem. The FDA is under tremendous
pressure from the MSG and food in
dustries to avoid placing a ban on the
use of MSG in baby foods . Such action
would represent official recognition
that MSG poses a significant hazard to
at least one large segment of the popu
lation, the immature human."

Banning the substances in baby and
junior foods is only one part of the pic
ture. "Young people, including infants
and young children, actually eat many
foods not specifically designated as in
fant or junior foods," Olney explains. "A
ban on MSG in infant and junior foods
does not actua Ily protect these young
people from MSG intake.
"Food processors in this country and
around the world add thousands of
tons of MSG to foods each year. Once
the FDA acknowledges that MSG poses
a hazard to young people, the only way
this sensitive population can truly be
protected against the hazard is to ban
aII use of the add itive. An alternate,
but somewhat less effective approach,
would be to require a label warning
that food containing MSG is hazardous
for the young. Obviously neither ap
proach is acceptable to the industries
concerned," 01 ney says.
According to Olney, baby food manu
facturers have used MSG as a flavoring
additive since the late 1940s. In 1969
it was brought out in Senate Nutrition
Hearings that infants have no taste for
MSG. It had been added solely for the
mothers' benefit. Later that year the
industry, while denying that MSG
posed a hazard to the developing brain,
announced they would voluntarily stop
using MSG in baby foods.
"This move had its intended effect,"
Olney says. "The public equated it
with an offic ia I ba nand developed a
secure feeling that their infants and
children were being maximally protect
ed. The facts are, however, that MSG
still is being added to the foods that
infants and children eat and the FDA
never has acknowledged that MSG is
hazardous to infants or to anyone else.

In his study of the effects of MSG and
other additives on small animals, John
W. Olney, M.D., utilizes the ultra-mi
crotome (far left). The device cuts the
brain tissue into minute sections. He
then mounts the pieces of tissue on
tiny copper grids (this page), and views
them under a microscope in order to
determine if brain damage has oc
curred
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" In 1970, the FDA referred the issue
to an industry-dominated panel of food
specialists, Their failure to question
the safety of MSG gave FDA the neces
sary backing to continue listing MSG
as 'generally regarded as safe (GRAS),'''
explains Olney,
" I cooperated fully with the panel,"
he says, "and I was very disappointed
when they wrote a pro-industry report.
I later learned that the chairman of
the panel had direct financial ties with
both the MSG and baby food indus
tries, In addition, most of the other
panel members were employed by or
otherwise financially dependent upon
the food industry, which paid thou
sands of dollars in 1970 to support the
panel's operations,"
As a witness at Senate Nutrition
Hearings in 1972, Olney testified that
the 1970 Advisory Panel on MSG was
riddled with conflicts of interest. He
noted panel members apparently had
been chosen for their industry loyalties
rather than scientific qualifications and
the panel demonstrated extreme biases
in dealing with the MSG issue,
He says he recommended that MSG
and all other questionable GRAS ad
d itives be re-eva I uated by a new com
mittee of truly qualified, independent
and objective scientists, It was this
committee wh ich recently unequ ivo
cally recommended that the FDA place
an official ban on the use of MSG in
baby and junior foods,
The other substance, HVP (hydrolyzed
vegetable protein) is relatively un
known to most consumers, HVP is a
product of hydrolysis, a method of
breaking down proteins into amino
acids such as MSG, Most HVP prepara
tions are rich in MSG and also contain
related molecules which act in con
cert with MSG to increase its brain
damaging potential, Olney says,
"Methods for preparing HVP from
proteins vary; some methods involve
removal of other ingredients to leave
almost pure MSG,
"The baby food industry began add
ing HVP to flavor infant foods at the
same time they agreed to stop adding
MSG," he says,
Olney reported his research on hy18

The powerful electron 'microscope is a key in strument in examining and photo
graphing brain tissue under study , The device enables Olney to detect the extent
of brain damage cells in animals that have been fed food additives,

drolyzed proteins two years ago in the
"New England Journal of Medicine."
These findings played an important
part in the conclusion of the FASEB
committee this month that HVP also
should be banned from use in baby
foods.
"I don't know why the industry is so
intent upon fueling consumer advocate
fires," Olney says, "but any way you
look it it, they only pretended to stop
adding MSG in 1970 and, in fact, have
been adding it all along."
When asked how much MSG has
been added under the HVP label, Olney
says: "I have no idea. Confront FDA
with this question and they refer you
to food industry representatives who do
not seem to know themselves. Since
the apparent aim in using HVP is to
get enough MSG into the food to give
it flavor, they probably have been in
troducing sUbstantia I concentrations of
MSG.
"In any event, the FASEB committee
would not have asked the FDA to ban
the practice if they did not consider it
potentia Ily detri menta I to the hea Ith of
infant and junior consumers."
While the FDA is deciding whether
to place a partial ban, full ban, or no
ban on MSG and HVP, Olney and his
research colleagues at the School of
Medicine intend to continue exploring
the effects of MSG and related com
pounds on immature brain and hor
mona I systems.
"These compounds are of extreme
interest to the neuroscientist," Olney
says, "because they excite nerve cells.
I started studying MSG back in 1967
because of this intriguing effect on
nerve cells, and it was largely by acci
dent that I discovered its brain damag
ing potential."
In the upcoming months, FDA hear
ings will determine what, if any, limi
tations wi II be placed on the use of
MSG and HVP in baby and junior foods.
If the two sUbstances are banned from
these foods, it is conceivable that fur
ther restrictions might be forthcoming
to protect children as they consume
foods not designated specifica Ily for
ba bies or jun iors.

Similar to the electron microscope is the leitz microscope which Olney also utilizes
to view and to photograph damaged brain tissue. This smaller microscope operates
at lower magnifications.
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Cancer
cenler
In 1970, a small group of scientists at
the Medical School formed a com
mittee to explore an idea they had
which would expedite cancer research
in the Medical Center.
Their concept was a cancer center
to coordinate and facilitate basic can
cer research throughout the Medical
Center.
Last month, this idea was fully re
alized with the dedication of the Cen
tralized Facilities of the Center for
Basic Cancer Research.
The Cancer Center was established
to provide a focus for research, teach
ing and seminar programs. It is also
responsible for defining which cancer
related areas need additional staff and
then recruiting the necessary people.
The Centra I ized Faci I ities were not
completed until last year because
the complex specialized center had to
be planned and constructed.
These faci I ities, located in the Mc
Donnell Medical Sciences Building,
are the core of the Cancer Center and
will provide services and supplies for
cancer research laboratories through
out the Medical Center. Tissue Culture
and Virus Production Laboratories will
produce large amounts of tissue cul
ture media, animal cells and viruses to
be used by investigators in their own
la boratories.
The Electron M icroscopy Center wi II
provide electron microscopy photog
raphy of viruses, cells and cell sur
faces.
Fewer than ten such centers exist in
the Un ited States. A unique aspect of
the facilities is that they will supply
services to researchers regardless of
depa rtmenta I lines.
"The main advantage of having one
faci I ity is that the basic work such as
media preparation and production of
viruses and cells can be accomplished
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in large quantities and distributed to
the researchers when and as they need
them," explains Heschel Raskas, Ph.D.,
associate director of the center. "Th is
saves the individua I investigators time
and money for equipment and supplies,
and allows them to become more in
volved with the creative aspects of their
research."
Robert E. Thach, Ph.D., director of
the center, explains another advantage

is the high level of expertise which can
be achieved by centralizing these ser
vices.
"Because it is a large facility which
services many investigators, we can af
ford to have the most advanced tech
nology available and an outstanding
staff," he says.
"There's a level of expertise in the
facility which few other laboratories
could hope to achieve. The technology
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Leonard Keay, PhD. , director of the
Tissue Culture and Virus Production Fa
cility, and John Mulkie , virus and cell
technician, examine a container of ce lls
which produce virus .
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Right: Darrel! Dobbertin, ass istant di
rector of the Electron Microscopy Fa 
cility using the electron micr oscope.
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Below: Keay in the virus lab's nega tive
press ure hood .
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would be impossible to duplicate,"
Thach says. "Some labs can do some
of the things we do, but none can do
all the things we're able to do."
More than 30 laboratories and 100
investigators uti I ize the services of the
Central Facilities.
Construction of the Center was fund
ed by a grant of more than $733,000
from the National Cancer Institute and
a contribution of more than $254,000
from Washington University.
The Center is a biohazard facility
which has been built to minimize the
dangers involved with working with
viruses. "The facilities are built so they
are sealed off from the rest of the
building," Thach says. "In addition,
careful safeguards to protect people
and the environment are followed."
Leonard Keay, Ph.D., director of the
Tissue Culture and Virus Production
Facility, says the facility has become
well-known a I ready. "We a I ready have
been asked by a manufacturing firm to
evaluate some equipment which can
produce cells on a large scale. We will
use the mach i ne for six months.
Chances are we will be asked to make
similar evaluations in the future."
Thomas Rucinsky is director of the
Electron Microscopy Faci Iity.
Although construction was completed
last year, the dedication program for
malized the opening of the Central Faci I ities. Two guest speakers attended
the program. Thomas J. King, M.D., di
rector of the Division of Cancer Re
search Resources and Centers, Na
tional Cancer Institute, spoke on "Basic
Research and the National Cancer Pro
gram." Howard M. Temin, Ph.D., McArdle Laboratory for Cancer Research
at the University of Wisconsin and the
1975 recipient of the Nobel prize in
medicine, also spoke on "RNA Viruses
and Cancers."
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Top: Heschel Raskas, Ph.D., associate
I
director of the center, with Howard M.
Temin, PhD., and Thomas J. King,
M.D., speakers at the dedication pro
gram, and Robert E. Thach, Ph.D., di
rector of the center.
Left: Pat Pruitt and Lavey McElroy
prepare and label containers for cell
media in the media preparation lab.
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WUMS stall melDbe..
t..avels 25,000 miles 10..
United Nations
When an official in the Ministry of
Education in Jakarta decides that ele
mentary school children need to learn
about population problems and family
planning, he can turn to a United Na
tions-funded clearing house in Bangkok
to find out how other countries have
developed such curriculums.
If a union official in the Philippines
decides large families of his union
members are eroding the gains he ne
gotiated in their pay scales, he can ask
a U.N.-funded clearing house whether
someone has devised a way to get this
point across to adult workers in col
loquial language.
If a village doctor in rural India finds
side effects occurring frequently after
insertion of IUDs, he can ask a clear
ing house in New Delhi for information.
It not only will provide him with med
ical advice, but also help in explaining
the problems to the village women,
especially to the midwives with whom
the women come in close contact.
These are only some of the services
U.N.-funded clearing houses provide.
Last autumn the U.N . Fund for Popu
lation Activities (UNFPA), sent a five
member mission to visit these clearing
houses in the Pacific region.
The American on the team was Es
telle Brodman, Ph .D., librarian at the
School of Medicine and professor of
medical history. The assignment lasted
about eight weeks, during which she
travelled some 25,000 miles.
The group was to determine how well
the clearing houses were meeting the
needs of the users in the area and
whether other needs were developing
which were not being met.
One of the questions facing them
was the necessity for national , rather
than
regional or global, clearing
houses. This issue is especially perti
nent in countries where English is not
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spoken, entailing translation of all ma
terials before any could be used.
This is not the first time Brodman
had worked in this geographic or sub
ject area. In 1961-1962, she was visiting
professor at Keio University in Tokyo.
In 1968 she was expert consultant to
what is now called the National Insti
tute for Family Planning in New Delhi.
In 1970 Brodman performed the same
task at the Regional Office of the World
Health Organization in New Delhi.
Th ree yea rs later, with a group of other
faculty from Asia and the West, she
presented a three-week workshop in
techniques for population documenta
tion centers in Bangkok. In the U.S.
she had been chairperson of a commit
tee of the U.S. Agency for International
Development which evaluated the work
of the Technical Information System
of the Carolina Population Council at
the University of North Carolina.
"It has been interesting to see the
changes in attitudes of individuals and
governments on family planning over
the years," she says. "Birth control is
still a term which few governments
wish to use, however, because of its
implications of pressure in a very per
sonal area of life. It may even connote
genocide in some cases."
However, "most governments now
have come to accept the fact that fam
ily planning and population dynamics
must be integrated with other subjects
to be acceptable to their citizens. That
is why population is now taught as part
of many subjects in schools." Brodman
says in some places they teach how to
figure percentages using examples
from population data.
She says since most of the popula
tion of southeast Asian countries are
illiterate, comic books, slide-tape pre
sentations, posters and other non-read
able media must be utilized. For exam
ple, the International Labor Office has
produced a series of large blocks with
pictures on them which can be used by
a speaker to illustrate his talks.
Confusion can result, though, when
countries exchange educational materi
als. A poster designed in southern Java
showed men and women in native In
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donesian dress; when it was used in
Malaysia, problems arose because the
clothing was so different they could
not tell the man from the woman.
And the world-wide problem of put
ting scientific concepts in layman's
language is complicated if the lan
guages are different th roughout the
country, such as in India, where there
are over 50 official languages. To over
come this problem, village officials, lo
cal school teachers and clergy are im
portant "filtering devices." "That is
why we tried to examine the position
of national and local clearing houses
in the scheme of things," Brodman
says.
The mission found many problems
with
local and
national clearing
houses. Countries are at varying levels
of sophistication in the use of any
means of scientific transfer. Even li
braries, Brodman says, which are taken
for granted in developed countries, are
new experiences for some countries.
"They don't know what such institu
tions can do for them, how they can
use them or how much money it would
take to run them. But it is a matter of
national pride in many places to say
the country has a national clearing
house."
Profound changes are taking place
in information processing, Brodman
points out. "A global population infor
mation network is technically possible
today, using computers and satellites,
but it may be too expensive and per
haps too sophisticated for some coun
tries to use such a system."
Many countries, she notes, do not
even have the back-up equipment
needed, such as photocopiers and mi
crofilm reading machines.
Before departing, the group was
briefed first at the U.N. in New York,
then at UNESCO (United Nations Educa
tional, Social and Cultural Organiza
tion) in Paris and finally at the WHO
(World Health Organization) in Geneva.
After the trip, the group reported in
person to the UNFPA before returning
home to write thei r reports.
Brodman says one of the human in
terest aspects of the trip was her ob

servation of changes in the area as a
result of the transformation of many
governments into one-party systems.
This had occurred recently in both In
dia and Thailand. In fact, says Brod
man, the change in government in
Thailand happened shortly before the
groups were scheduled to go to Bang
kok. There was some question at that
time whether it would be safe for the
mission to visit that city.
"But everything seemed very quiet
all the time we were there," she says.
"There were curfews and soldiers in
evidence everywhere, but for the most
part the people were going about their
regular business just as always.
"It was i nteresti ng to see the d iffer
ences in the various non-democracies,"
she says. "In India, for example, there
were large billboards and signs on all
the buses with Mao-like injunctions,
such as 'Talk less and work more,' or
'Be kind to visitors.' Newspaper ads
pledged loyalty to the programs of Mrs.
Gandhi, and there was little criticism
of the government in the papers,"
Brodman says. Because India had had
monsoons and several good years for
crops, she says most people were bet
ter off than when she last visited the
country.
One of the effects the non-democrat
ic governments have on the clearing
houses is the i nsta bi I ity of the mem
bers of the government. "They are
moved around from position to posi
tion, often before they have ti me to
learn the problems in that position."
She says such officials "often make de
cisions about clearing houses which
might be the opposite of what their
predecessors did. This results in wast
ed time and energy." The problem is
wide-spread, she says, because in Asia
all important institutions are parts of
the governments.
Of all the cities she visited, two were
important-Bangkok
and
especially
New Delhi. Each had two clearing
houses funded by the UNFPA, and
each had to decide what their future
courses would be. The fifth institution
she visited, the Press Foundation of
Asia, was in Manila. Brodman also con
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Helen Lewis-Jones (left), Program Officer for the U .N . Fund for Population Activities, consults with Estelle Brodman, PhD .
Lewis-Jones ca me to St. Louis to collaborate with Brodman in compiling a final report .
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suited with officials in Pakistan and In
donesia.
In Bangkok, ESCAP (Economic and
Social Council for Asia and the Pacif
ic) has had a clearing house since
1971. "As the oldest and largest one,"
she says, "this clearing house has been
asked to do a great many things, and
unfortunately has tried to respond to
all requests.
"It was tremendously successful at
the beginning, but now they have
spread themselves too thin," she says.
"They're either going to have to stop
some programs or get more people and
money to carry them on. I'm inclined
to think that the recent UNFPA deci
sion to put more resources into nation
al projects and fewer into regional and
global projects will make it difficult for
them to get the money that is needed
for everything."
The other clearing house in Bangkok,
UNESCO, has a more limited audience
and an even more limited group of ser
vices, she says. Because of this, the
center can delve into problems more
deeply. The UNESCO clearing house
has mobile teams which visit other
Asian countries upon invitation from
the governments. There they work with
the local officials on their education
problems and collect local "fugitive"
or hard-to-Iocate literature for sending
back to Bangkok.
The literature usually is items either
mimeographed or typewritten, pub
lished in only a few copies for local
use, but might contain data or statis
tics usefu I to other groups in other
countries. Unless they are obtained
quickly, Brodman says, it may not be
possi ble to ever find a copy.
In New Delhi, she says, the mission
found two different types of clearing
houses. One at the National Institutes
for Family Planning and the other at
the regional Office of the World Health
Organization.
Brodman says it was difficult to com
pare because the two had very differ
ent aims. The group felt, however, that
the WHO had emphasized reviews of
the literature rather than individual
ized services. "It also serves only the
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elitist medical groups in the area, with
no one there to translate its findings
into language understandable to policy
makers and communication workers."
Almost all clearing houses publish
newsletters, lists of new books and
journal articles, translations and kits
of "how to" materia Is. The centers a Iso
distribute pUblications to people work
ing with and researching population
problems.
Almost all of the clearing houses
have networks of correspondents in
cities throughout the region to alert
them to important news.
"One of the most interesting ways
that we saw of dispersing information
about population and family planning
is used by the Press Foundation of
Asia in Manila . The Foundation utilizes
free
lance
newspaper
reporters
("stringers") throughout southeast Asia
for stories on population. They collect
the stories and furnish them to other
newspapers, translated into local lan
guages.
In this way, Brodman says, the Press
Foundation hopes to replace the over
whelming abundance of stories in the
papers about the "developed" world
with articles on developing nations.
When asked for her view of the fu
ture of population clearing houses, she
says, "the future course of population
documentation centers and clearing
houses is uncertain.
"On the one hand, computers and
communication by satellite offer sev
eral possible global network roads. On
the other hand, strengthening tradition
al libraries and knowledge resource
bases might be the path for the next
decade or so.
"Population itself, as now defined,
may become so 'integrated' with other
important social areas as to lose its
singular identity. The present view,"
Brodman says, "is that population and
family planning should be woven into
the rest of life, rather than being con
sidered a separate issue. It certainly is
more effective when each aspect rei n
forces the others."
An example Brodman gives of this
integration is lifestyle changes, such

as urbanization of families without ex
tended family groups and more women
joining
the
labor
force.
"These
changes, interwoven with population
planning, are all mutually conducive
to family planning."
One aspect that bothered her, she
says, is that nobody seemed to be pay
ing enough attention to the future of
population documentation centers and
clearing houses, not only in Asia, but
also internationally.
"The changing definition of popula
tion, differing emphasis on population
matters in many countries, the rise of
nationalism everywhere and the new
technology of communication all tend
to foretell a change in the position of
population documentation centers.
"What, for example, will be the rela
tionship between national clearing
houses and regional or global ones?"
Brodman asks. "Who will take on the
'neutral' stance of the international
group, whereby information is provided
to countries who do not talk to each
other directly, if regional clearing
houses are dismantled? And who will
provide the personalized services in
their own language, which are now of
fered by national and local clearing
houses if there are only regional and
i nternationa I ones?
"Finally," Brodman says, "who wi II
care for population, narrowly consid
ered, if only an umbrella-type clearing
house for social affairs in developing
countries remains?"
Brodman says these are the ques
tions she would like to see addressed
in the near future.
Why did the UNFPA select her for
the mission? "Well, they needed some
one who knew something about the
area, who was a librarian, and who
could go at the time that the mission
was scheduled to leave. I guess I fitted
those requirements," she says.
Brodman says this will probably be
her last mission to the East, as future
evaluations are likely to occur after her
retirement. Her work in the transmis
sion of scientific information will con
tinue, however, but with a St. Louis
base.

..

•

I

I

Elcele..a

In recognlrlon of

The Ufe Serving Achlevemen~ of Medeol 5dence

A TPJDUTE TO ,
ST. LOUIS' MEDICINE
JANUARY 9-16, 1977

-

.- 

. ~
. 1"'~~·

,I

.::::::-;:.~

.(..
~-r"::::
::.~
___ ,.,,..ir .,.,....

~~

• lIf·~
~~'

..........
,..,.
.. \.,.
."...
. - ..I"

--..... ........

.~~

..

.~

.,..,.

-

_..r.

--'''''''''''' . ... ::::'~
~

William H . Danforth, M .D., Chancel/or of Washingt on University, and Mrs. Danforth read over the ach ievements of Wa sh ing
ton and St. Louis Universities Medi ca l Centers at th e Tribute t o St. Loui s Medicin e Dinner wi th Bernard A. Ehrenreich , execu
tive dire c tor of the St. Louis ch apter of the March of Dime s Fou ndatio n.

WUMS Honored
During St. Louis
Medicine Tribute
Oliver H. Lowry, M.D., Ph.D., profes
sor of pharmacology and former head
of the department, was honored for his
contri butions to the advancement of
medical science last month during a
week long Tribute to St. Louis Medi
cine.

Goronwy O. Broun Sr., M.D., dean
emeritus and professor of medicine at
St. Louis University also was recog
nized .
The St. Louis area chapter of The
Birth Defects' March of Dimes Founda 
tion sponsored the event to pay tribute
to medicine in general, individual mem
bers of the profession and Washington
.and St. Louis Universities Medical Cen
ters for their " tremendous accomplish
ments in improving the public health,
particularly in the past 50 years."

Community leaders joined the March
of Dimes to make the week a success.
Broun and Lowry were recognized at a
banquet which culminated the tribute.
Lowry was honored for his nationa Ily
recognized studies of the nervou s sys
tem.
The recipient of many nationa I
awards and a member of the National
Academy of Science, Lowry is world
renowned for his work in microtech 
niques as well as for other research.
Dr. C. Rollins Hanlon, Chicago, pres
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Etcetera

ident of the American College of Sur
geons was the principal speaker at the
dinner.
Dr. Rollins spoke on "Medicine:
Where We Are Going; Where We Have
Been."
Howard M. Love, president of Na
tiona I Steel Corp., and cha i rman of the
St. Louis Medicine Week said, "The
achievements of medicine in every
area of health care has been enormous,
particularly in the past 50 years. We
feel that the time is long past due to
recogn ize these contributions.
"We want all deserving persons and
institutions in medicine to know that
we respect and appreciate what they
have accomplished in furthering the
public health and in contributing to the
well-being of our fellow citizens through
their scientific research, through treat
ment and devotion to the principles of
their profession," he said.
The program paid particular tribute
to the achievement of the medical
schools of Washington and St. Louis
Universities, local practitioners, scien
tific researchers and members of the
nursing and related professions.

Names Make News
Carl Frieden, Ph.D., professor of bio
logical chemistry at the School of Med
icine, has received the 1976 St. Louis
Section American Chemical Society
Award.
The award is presented annua lIy for
outstanding contributions to chemistry.
Frieden's particular area of research
interest involves enzyme kinetics and
the mechanism of enzyme action.
He is a graduate of Carleton College
and of the University of Wisconsin,
where he received his Ph.D.
Eli Robins, M.D., Wallace Renard Pro
fessor of Psychiatry, will receive the
Paul H. Hoch award from the American
Psychopathological Association on
March 3. He will receive a gold medal
and cash award at the Association's
67th annual meeting at the Hotel
Americana in New York City.
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Dr. Robins wi II receive the award for
his lifetime research in the field of
psychiatric illness, with a special em
phasis on his clinical psychiatric re
search, and the diagnosis, treatment
and classification of psychiatric ill
nesses.

Researchers Test
Time-Release
Contraceptive
A new time-release contraceptive
which is injected into the cervix is be
ing developed at the School of Medicine.
However, un I ike other contraceptive
inoculations, this one should not affect
the menstrual cycle nor prevent ovula
tion.
David W. Keller, M.D., assistant pro
fessor of obstetrics and gynecology, is
researching the procedure which con
sists of injecting microscopic capsules
beneath the surface of the cervix. The
micro-capsules contain time-release
doses of progesterone.
Progesterone, a female hormone, acts
upon the cervical mucus, making it hos
ti Ie to sperm penetration.
"We're not using a synthetic prepara
tion," Keller stresses. "A woman's body
naturally produces progesterone. In the
midd Ie of her cycle, protein fibers in
the cervical mucus are optimally
spaced for sperm passage. After ovula
tion progesterone is produced and the
fibers intermesh. This position change
makes it impossible for sperm to pass
between the fibers and into the uterus."
Keller hopes to duplicate the natural
progesterone production so the fibers
will block sperm passage every day of
the menstrual cycle.
He estimates the injections would be
effective for about a year. The method
is not designed for those who might
soon change their minds about having
a child, Keller says. However, he will be
studying the possibilities of reversing
the procedure. Work on the new con
traceptive is funded by a grant from
Northwestern University, Evanston, III.

Robert E. Sparks, Ph.D., professor of
chemical engineering at Washington
University, is assisting Keller. "Dr.
Sparks is seeking to find a method of
putting the hormone into the micro
capsules so they will be time released,"
says Keller. "If they can be implanted
once a year, it will be more convenient."
Keller and Sparks are testing the in
jections on cattle at the University of
Missouri-Columbia . "We are studying in
vitro sperm penetration," he expla ins.
"We already can decrease sperm pene
tration significantly. We are planning to
test the fertility of the animals and then
develop reasonable release rates for the
capsules.
"We hope to see its effectiveness in
the next six months," Keller says.
"We're just starting to measure the re
lease rate of progesterone."
The contraceptive injections are ad
vantageous because they should not in
terfere with the menstrual cycle. "This
has a local effect only," Keller says.
"There are no pain fibers in the cervix
so it is a conven ient place to do this
type of injection. It is relatively pain
less."
Keller also foresees the possibility of
utilizing an air gun such as those used
by dentists, thus eliminating the need
for a needle. The capsules would be
shot directly into the cervix, being
propelled by compressed air within the
gun.
"It is not the answer to America's
contraceptive problems, though," he
says. "It is designed for people with
relatively poor motivation, such as
those who cannot remember to take a
pill or who will not USe other devices.
This would be an alternative to steri
I ization, for someone who needs long
term contraception but who does not
want to be sterilized."

Multiple Sclerosis
Grant Received
The School of Medicine has received
a three-year grant of $104,890 from the
National Multiple Sclerosis Society to

continue support of research by Rich
ard Bunge, M.D., professor of anatomy
and neurobiology. Patrick Wood, Ph.D.,
research instructor, will collaborate
with Bunge in this work.
Bunge is studying myelin-forming
cells. In multiple sclerosis, for reasons
not yet understood, the myelin sheath
of the central nervous system nerve
fibers is damaged and destroyed.
Bunge hopes to gain a better under
standing of how the number of my
elin-forming cells in the central ner
vous system is determined, how they
are induced to form myelin sheaths,
and to learn why the normal number of
myelin-forming cells sometimes is not
restored when the myelin sheath breaks
down. In addition, he would like to bet
ter understand why supporting cells are
able to reform myelin sheaths in cer
tain demyelinating conditions and not
in others.
This grant brings the Society's sup
port of Bunge's research to $350,227
since 1960.

Students Honored
For Scholastic
Excellence
Twenty-four students at the School of
Med ici ne were honored for scholastic
excellence during the 1975-76 academic
year at a December Awards Assembly.
Awardees from the St. Louis area and
thei r honors are:
Michael R. Green-Carl F. and Gerty
T. Cori Prize in Biochemistry, for
superiority in the field;
Peter L. Jacobson-Lange Medical
Publications Book Award for high aca
demic standing during the junior year;
Thomas R. Kleyman-Lange Medical
Publications Book Award for high aca
demic standing during the sophomore
year;
Keith L. Parker-Carl F. and Gerty T:
Cori Prize in Biochemistry for superior
ity in the field;
Lee S. Portnoff-Lange Medical Pub

lications Book Award for high academic
standing during the sophomore year;
John J. Schier-Lange Medical Publi
cations Book Award for high academic
standing during the junior year;
Kenneth N. Scissors-Ciba Book
Award for laudable extra-curricular
community service.
Other students honored include:
Kendall H. Barker, Grosse Pointe
Farms, Mich.-Dr. Robert Carter Medical
School Prize, for meritorious perform
ance during the freshman year;
George A. Chaitkin, Skokie, II I.-Carl
F. and Gerty T. Cori Prize in Biochemis
try for superiority in the field;
Patrick N. Dwyer, Ruxton, Md.-Dr.
Richard S. Brookings Medical School
Prize for meritorious performance dur
ing the junior year;
Mitchell P. Fink, San Rafael, Calif.
a Medical Alumni Scholarship Fund
Prize for scholastic excellence;
Erik M. Gregorie, Alexandria, Va.
Gill Prize in Anatomy for outstanding
anatomical work;
Robert A. Gross, Worcester, Mass.
Edmund V. Cowdry Prize in Histology
for outstanding performance in micro
scopic anatomy ;
Bruce A. Kraemer, Tulsa, Okla.
Lange
Medical
Publications
Book
Award for high academic standing dur
ing the freshman year;
Joan K. Kreiss, Princeton, N.J.-Dr.
Margaret G. Smith Award for outstand
ing achievement by a female student
during the first two years of medical
school;
Timothy J. Ley, Lakota, Iowa-Dr.
Richard S. Brookings Medical School
Prize for meritorious performance dur
ing the sophomore year;
Steven McGee, Portland, Ore.-Antoi
nette Frances Dames Prize in Physiol
ogy and Biophysics for scholastic
superiority in the fields;
Ross E. Morgan, Wheat Ridge, Colo.
Dr. Robert Carter Medical School Prize
for meritorious performance during the
sophomore year;
Timothy Patton, Lacey, Wash.
Chouke Prize in Anatomy for superior
scholarship in the field;

Victor L. Schuster, Glenwood, lowa
Dr. Robert Carter Medical School Prize
for meritorious academic performance;
James E. Schwob, Iowa City-Lange
Medical Publications Book Award for
high academic standing during the
freshman year;
Allen J. Sedman, Southfield, Mich.
Antoinette Frances Dames Prize in
Physiology and Biophysics for scholas
tic superiority in the fields;
Mark C. Udey, Ft. Atkinson, Wis.
Dr. Richard S. Brookings Medical
School Prize for meritorious perform
ance during the freshman year;
Stephen G. Young, Topeka, Kan.-Mc
Cordock Book Prize in Pathology for
general excellence in the field.

Students Named
ToAOA
Twenty-one students at the School
of Medicine have been elected to Alpha
Omega Alpha by the faculty and the
135 seniors .
AOA is a national honorary society
recognizing outstanding scholarship and
leadership in medicine and related
fields. It is considered the most pres
tigious honor society in med ici ne.
St. Louis area students elected to
the society are: John W. Campbell,
David D. Desper, Peter L. Jacobson and
John J. Schier.
Other students elected include: Laird
A. Bell, Overland Park, Kans.; James T.
Brown, Springfield, Mo.; Charles Carras
co, Ogden, Utah; Patrick N. Dwyer, Rux
ton, Md.; Mitchell P. Fink, San Rafael,
Calif.; Pamela G. Freeman, Clarkston,
Ga.; G!enn S. Gollobin, Teaneck, N.J.;
Warner C. Greene, Mesa, Ariz.; Kay Mil
ler, Mill Valley, Calif.; Duane L. Mitzel,
Vallejo, Calif.; John W. Ogle, Denver,
Colo.; Thomas E. Phillips, Manhattan,
Kans.;
Victor L. Schuster, GlenWOOd, la.;
James W. Steger, Prospect, Ky.; How
ard G. Welgus, Flushing, N.Y.; Richard
F. Williams, Mt. Vernon, Mo.; and Scott
W. Younkin, Springfield, III.
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Class Noles
'205

'50s

Sol Londe, '27, St. Louis, is retiring
from the practice of pediatrics. Dr.
Londe is an associate professor of pedi
atrics and has been on staff at W.U.
for more than 40 years.

Kenneth Huey, '55, Sun City, Ariz., has
been elected chief of the medical staff
at Boswell Memorial Hospital.

'305
James F. Nolan, '38, Los Angeles, was
honored at a testimonial dinner given
by the Alumni Association of Cali
fornia Hospital. A. N. Arnesen, '28, Hen
ry Schwarz II, '41, Theodore A. Lynn, '38,
Louis Hemplemann, Jr., '38, participated
in the program.
Irving L. Berger, '39, Cleveland, is presi
dent-elect of the American Group Psy
chotherapy Association.

'405
Gordon F. Moore, '40, Alton, III., was
honored at a dinner by the citizens of
Alton for his outstanding contributions
to the community. The city dedicated
a park in his honor which will be of
ficially called the Gordon F. Moore
Park.
Ewald W. Busse, '42, has been named
the Associate Provost and Dean of Med
ical and Allied Health Education at
Duke University Medical Center, Dur
ham, N.C.
William L. Topp, '41, Seattle, was elect
ed chief-of-staff of the Virginia Mason
Hospital.
Edward J. Twin, '45, Kansas City, Mo.,
is the executive director of the New
Truman Medical Center, Primary Teach
ing Hospital for UMKC. He also is a
member of the Missouri State PSRO
council.
Robert A. Huckstep, '48, has served 12
years on the school board of the Farm
ington RVII school district, and for
three years as president of the Gov
ernor's Conference on Education.
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Eugene Nagel, '59, is now professor and
chairman of the Department of Anes
thesiology at Johns Hopkins University.
David L. Winter, '59, Washington, D.C.,
NASA Director for Life Sciences, was
elected corresponding member of the
International Astronautical Academy.
James H. Dunlevy, Jr., '51, Fairfield,
Iowa , has finished one year as presi
dent of the Jefferson County Medical
Society. He has served on the execu
tive council of the Lutheran Church in
America for the past seven years.

'60s
R. Michael Sly, '60, professor of pedi
atrics and director of Pediatric Allergy
and Immunology at Louisiana State
University Medical Center, New Orleans,
has written a book entitled Pediatric
Allergy .
Robert Waldman, '63, Morgantown, W.Va.,
has been named professor and chair
man of West Virginia University's De
partment of Medicine.

associate professor of orthopedics and
rehabilitation, and associate professor
of anatomy at Vanderbilt University.
Morris W. Pulliam, '66, was appointed
assistant professor of neurological
surgery, University of Missouri and
chief of section of neurological sur
gery, Veterans Hospital, Columbia.

'70s
John D. Reinhard, '73, Chicago, was
awarded the Norris L. Brookens Award
from the Illinois Society of Internal
Medicine. This award is given to the
most outstanding resident in internal
medicine in the state.
J

James Seegers, '73, received a MAP
Reader's Digest International Fellow
ship. Dr. Seegers is assigned to Mon
rovia, Liberia for three months. Made
possible by a grant from the founder
of Reader's Digest, DeWitt Wallace, the
program provides three-month assign
ments to rural mission hospitals and
clinics in remote parts of the Third
World.
Lee A. Rigg, '71, La Jolla, Calif., has
completed residency in OB / GYN and
a post-doctoral fellowship in Repro
ductive Endocrinology.

Charlie W. Shaeffer, Jr., '64, Palm
Springs, Calif., is the chief of cardiol
ogy at Eisenhower Medical Center, Palm
Desert.

Former House
Staff and Former
Faculty

Elliott Prather Palmer, '66, recently has
been appointed to the associate staff
in the Department of Neurology at the
Lahey Clinic in Boston. Dr. Palmer is
a member of AMA and a junior mem
ber of the American Academy of Neu
rology .

Ian M. Smith, M.D., Johnson City, Tenn.,
has been appointed professor and
chairman, Department of Internal Med
icine at the new medical school, East
Tennessee State University.

Ronald E. Rosenthal, '61, Nashville, was
recently awarded an NIH grant to con
tinue "Studies of Synovial Response to
Acute Trauma." He also was appointed
to the Tennessee Chapter of the Com
mittee on Trauma of the American Col
lege of Surgeons, and will continue as

Heskel M. Haddad, M.D., is editor-in
chief of Metabolic Ophthalmology, a
new international journal of basic re
search and clinical applications. The
magazine is the official publication of
the International Society on Metabolic
Eye Disease.

'J

Howard N. Ward, M.D., is the director
of Medical Education, Stormont-Vail
Hospital, Topeka, and assistant pro
fessor of medicine at the Kansas Uni
versity Medical Center.
Leonard Wartofsky, M.D., Kensington,
Md ., has been appointed chief of the
Kyle Metabolic Unit and Endocrine
Metabolic Service of the Walter Reed
Army Medical Center.
J. Joseph Marr, M.D., is professor of

medicine and microbiology and Director
of the Division of Infectious Diseases
at St. Louis University Medical School.

Health Care
Administration
Stephen M. Patz, '69, has authored an
article entitled "One Hospital's Ap
proach to Word Processing" which was

published in the October issue of Med
ical Record News. Patz is assistant ad
ministrator at Sinai Hospital of De
troit.

James A. Felts, assistant professor of
anesthesiology at Washington Univer
sity School of Medicine, was re-elected
Speaker of the House of Delegates of
the American Society of Anesthesiol
ogists at the annual meeting which was
held in San Francisco in October.

Washington University Medical Center Alumni
Contributors-1 976 Student Loan Fund
Over the years this Fund has assisted scores of Washington University medical students in meeting their expenses, especially
those of an emergency nature. As educational costs continue to rise, the Fund assumes increasing importance.
Grateful thank s is extended to all 1976 contributors .

FACULTV AN 0 FORM ER
HOUSE OFFICERS
Charles L. Abramson
Elisha Atkins
Charles L. Abramson
Elisha Atkins
Wagih A. Bari
Andrew M. Brown
Samuel Canaan
John W. Cavo
Robert S. Cohen
K. C. Das
Donald Dickler
Ira J. Friedman
Florentina U. Garcia
Richard P. Gerhardstein
Percy V. Gladdy
Alan C. Goodman
Gerald Gordon
Thomas Hamilton
Margaret Hayes
Albert E. Hesker
Robert W, Huntington
Richard E. Johnson
Donald C. Johnston
Stephen Kessler
Frank H. Kidd, Jr,
David Kipnis
Ruth Kramer
Morton R. Lazar
Arnold Markowitz
J. Guerra Medina
William T, Newton
William R. Oakes
W. H. Oehlert
Reynaldo Pagtakhan

Francis J. Riley
Bahij S. Salibi
Isa A. Samad
Ernest W. Saward
Stephen G. Sinclair
Sterling B. Suddarth
Francis J. Troendle
Ed ith Trugly
Raymond E. Yadon
Hector leva Ilos
CLASS OF 1927
Theodore Fischer
CLASS OF 1928
Robert H. Riedel
CLASS OF 1929
Pau I R. Boren
Alexander Freshman
Gabriel A. Rivera
CLASS OF 1930
Donald E. Eggleston
Edmund H. Werling
CLASS OF 1931
Benjamin D. Friedman
H. Lee Hoover
CLASS OF 1932
Edwin K. Chunghoon
Edward J. Kloess
William H. Meinberg
Sydney S. Pearl
George M. Powell
Arthu r Steer

CLASS OF 1933
Angelo Bologna
William F. Wenner
Edwin R. Westbrook

CLASS OF 1940
David Goldring
Charles G. Obermeyer
John S. Skinner

CLASS OF 1934
James M. Baker
Ben P. Frissell
Ralph R. Jones
Jean F. Rogier
Keith S. Wilson

CLASS OF 1941
Randall Connolly
Anne T. Goetsch
John P. Lee

CLASS OF 1935
Carl H. Hamann
Nathan K. Jensen
Clark G. Porter
CLASS OF 1936
Merri II C. Davenport
Edgar L. Engel
Nathan R, Kahn
John W. Records
Robert H. Rutherford
Robert T. Tidrick
Michael S, Wepprich
Robert A. Wise
CLASS OF 1937
Lloyd E. Rosenbaum
CLASS OF 1938
Alfred Golden
J, Robert Mangum
Frank J. Weber, Jr.
CLASS OF 1939
Mark J, Brockbank

CLASS OF 1942
William M. Anderson
William A. Black
Herman T. Blumenthal
Irving A. Kotner
Herman Rice
CLASS OF 1943M
Edward H. DUnn
Robert B. Pappenfort, Jr.
Wilfred E. Wooldridge
CLASS OF 19430
John H. Eisenhauer
James G. Owen
James C. Vest
William S. Welborn
CLASS OF 1945
John C. Herweg
George L, Rider
CLASS OF 1946
Jack Barrow
Boyd E, Hayward

Andrew S. Lanier
Nicholas H. Nauert, Jr.
CLASS OF 1947
Kenneth R. Dirks
H. L. Townsend
CLASS OF 1948.
Lyle W. Burroughs
Everett R. Lerwick
Jacob Malin
Helen A. Stokinger
CLASS OF 1949
Louis Kurahara
John F. O'Brien
Dale M. Schulz
CLASS OF 1950
Walter C. Adams
Peter L. Hurst
Robert I. Pfeffer
Frank J. Skerbeck
Richard L. Swarm
Gloria W. Troendle
William R. Vineyard
CLASS OF 1951
Melvin L. Faw
Ann Hunt
Max K, Mendenhall
Orin J. Riddell, III.
CLASS OF 1952
Eric I. Anderson
Frank W. Clippinger, Jr.
William R. Cole
Mary A, Davis
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Class Notes

Albert T. Nambu
Sherman O. Schachter
Ronald L. Scott

CLASS OF 1953
William F. Capps, Jr.
Paul W. Herron
John R. Lichtwardt
Malcolm H. McGavran
Dona ld C. Meredith
Donald Rin sley
CLASS OF 1955
William C. Barrette
Waller W. Cooper
Richard R. Dewey
Robert C. Drews
L. Bruce Ell is
Selna L. Kaplan
Glendall L. King
Fred T. Kraus
Martin E. Liebling
Charles W. Markham
Miles C. Whitener
CLASS OF 1956
Robert H. Duem le r
Harriet S. Kaplan
John S. Meyer
Ethelee R. Smith

j:

!I

CLASS OF 1957
Zachary A. Apfel
Carlton M. Dean, Jr.
Paul L. Friedman
Harry C. Gibson
Thoma s A. Heckel

Robert C. Meredith
Lawrence C. Paku la

CLASS OF 1958
Thomas C. Apostle
Eugene F. Bartlett
Malcolm B. Bowers, Jr.
Ronald J. Catanzaro
Michael Gass
Robe rt L. Glass
William I. Goettman
John A. Headrick
Dan iel F. Keller
David M. Ke ssner
Lucy J. King
George A. Koehler
Robert F. Meger
Robert B. Winter
CLASS OF 1959
Murray H. Helfant
Hugh F. Keister
F. Calvin Lemon
Irving M. Stillman
CLASS OF 1960
Mark Abramowicz
Robert E. Fec hner
Edgar G. Givhan
William B. Grubb, Jr.
George P. Hoech, Jr.
Donald C. Sauer
John S. Schoentag
Hillel Tobias
Phillip E. Winter
R. Dean Wochner
Gabriel S. Zatlin

CLASS OF 1961
George E. Dueker
James G. Hollingsworth
Kent E. Keller
John D. Morgan
Gary A. Storey
Shigemi Sugiki
CLASS OF 1962
Robert Edelman
James R. Goggin
Joel B. Kirkpatrick
Gerald Medoff
Laurence W. Muench
John D. Rich
John E. Rittmann
Timothy W. Steven s
CLASS OF 1963
Stanford K. Au
Ronald W. Barnet
Gary M. Boelling
John P. Christy
Donald W. Humphreys
Robert S. Hunt
David L. Nelson
Lawrence M. Unger
Eugene J. Valentini
CLASS OF 1964
G. Arthur Carder
Max L. Elliott
Ann B. Fletcher
Raymond Fletcher
David L. Mcilwain
John E. Munzen rider
Robert G. Scheibe

I

CLASS OF 1965
F. Eliska Atkin s
David L. Dunner
Thomas F. Frist, Jr.
Alan S. Hendin
Warren B. Howe
Carl G. Kardinal
Barry B. Kirschbaum
Albert H. Krause
Robert B. Telfer

Penelope Shackelford
Lynn M. Taussig

CLASS OF 1966
Markham J. Fischer
Gilbert J. Gordon
H. Michael Jones
Jerome H. Kaplan
Daniel J. Leary, Jr.
David L. Polage
Carl F. Ritter
Walter D. Stevenson, III.
Leslie A. Torgerson

CLASS OF 1970
Eugene L. Crews
Joanna L. Data
James M. Mick
Alexander L. Miller
Lyle D. Pahnke
Peter J. Stern

CLASS OF 1967
Milton S. Bleiweiss
Allan C. Campbell
Gary S. Rachelefsky
Robert D. Shay
Michael R. Trei ster
Ronald H. Ullman
Frank Vin icor
Andreas M. Walchner
CLASS OF 1968
Hunter Heath, III.
Susan G. Odom
Seymour Packman
Maribeth P. Sayre
Gary D. Shackelford

CLASS OF 1969
Thomas R. Bates
John C. Long
Thomas B. Hall, III.
Edward L. Knute son
Robert C. Kolodny
Barry A. Siegel

CLASS OF 1971
Oren M. Conway
David L. Diedrichsen
Jane B. Diedrichsen
CLASS OF 1972
Thomas C. Hill
CLASS OF 1973
Edward H. Birkenmeier, III.
Edward W. Knowlton
CLASS OF 1974
Peter GI ickman
Jon F. Moran
Alan J. Tiefenbrunn
CLASS OF 1975
Jo-Ellyn M. Ryall
John W. Ze l ler
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Continuing Medical Education Calendar
DATE

PROGRAM

Ma rch 7-May 23

Internal Medicine Board Examination Review

Apri I 11-12
Apri I 21-22
Apri I 21-23
April 22
May 5-7
May 11-13

4th Annual Symposium on Obstetrics & Gynecology
The Borderline Child
Eye Residents Seminar
.. ....... .
An Approach to the Patient With Diarrhea
... . . .. .
Jewish Hospital Medical & Surgical Program
Washington U. Med. Center Alumni Reunion

May 18
May 20-21
May 26-27
June 9

Surgical Problems in Chi Idren
Neuromuscular Diseases
Current Topics in Hypertension & Its Management
Perinatal Medicine
.
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CHAIRMAN
· ... Russell Eggebrecht, M.D.
Richard Ratzen, M.D.
. . . . . . .. . George Wulff, M.D.
.. Doris Gilpin, M.D.
........... Robert Feibel, M.D.
. . Gary Zuckerman, D.O.
. Jerry Meyers, M. D.
. .. Robert Karsh, M.D.
Edward Lansche, M.D.
Robert Packman, M.D.
Edward Reinhard, M.D .
. . . .. ' " . . .... Martin Bell, M.D.
· . . . Michael Brooke, M.D.
· .. . H. Mitchell Perry, Jr., M.D.
. ... Richard Marshall, M.D.

Vice Chancellor Comments:

1
,\

I

I
I
r

~

" To be worthy to serve the sufferi ng"
is the motto of Alpha Omega Alpha, the
medical honor society. The motto ex
presses beautifully the high ideals of
our profession. It re cogni zes that it is
a privilege to be a physician-a privi
lege, much sought after and widely
respected , that must be justified
throughout one's professiona I life.
Physicians justify their privilege s by
adh ering t o a code of honor that governs
their dealings with the sick and injured
and with on e an other. No profe ss ion
ca n hope to enj oy society's trust with
out such a code that truly guide s and
and fortifies its practitioner s.
At different times and in various
pla ces, such code s for physici an s have
been expressed differently, but they al
way s demand co mmitment-through
se lf-disc ipline, hard work, and personal
sacrifice-to med ic ine's high ideal of
devotion to the suffering. Further, phy
sicians are expe cted never to f orget
their debt to soci ety for having edu
cated and tra ined them and their debt
to patients who allowed. them to par
ti c ipate in their ca re and so learn to
be phy sic ians. Honor obligates us to
acknowl edge our debts to tho se who
made our privileges possib le and re
Quires us t o repay in kind the sac ri
fices of othe rs made in our behalf.
Great professional privilege-su ch as
that enjoyed by physicians-can only
be coun tenanced when co upled to a
demanding code of responsi bility and
obligation to which the profession
gladly adheres. Su ch codes, like our
bodies, beco me flabby when not sub
jected to regular exerc ise and chal
len ge. They are then easily compro
mised or even dismi ssed cyn ica lIy when
con fronted by economi c, soc ial, and
political "realities." But we must neve r
misunderstand: our priv ileges are in
separably linked to our obligations. If
the latter become "unrealistic" or "out
moded," the former will surely disap
pear.
Samuel B . Guze, M.D.
Vice Chancellor for Medical Affairs

